Evidence map›Paper›PMID 35791014›Full record

ArticleBMC health services research2022

Co-implementing vitamin A supplementation with seasonal malaria chemoprevention in Sokoto State, Nigeria: a feasibility and acceptability study.

Olusola Oresanya, Abimbola Phillips, Ekechi Okereke, Abraham Ahmadu, Taiwo Ibinaiye, Madeleine Marasciulo, Charlotte Ward, Olatunde Adesoro, Rilwanu Mohammed, Jamilu Nikau and 6 more

Open access · goldAbstract read
In one paragraph

Article in BMC health services research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 3 countries.

Olusola OresanyaMalaria Consortium Nigeria, Abuja, Nigeria. o.oresanya@malariaconsortium.org.
Abimbola PhillipsMalaria Consortium Nigeria, Abuja, Nigeria.
Ekechi OkerekeMalaria Consortium Nigeria, Abuja, Nigeria.
Abraham AhmaduMalaria Consortium Nigeria, Abuja, Nigeria.
Taiwo IbinaiyeMalaria Consortium Nigeria, Abuja, Nigeria.
Madeleine MarasciuloMalaria Consortium United States, Raleigh, NC, 27615, USA.
Charlotte WardMalaria Consortium United Kingdom, London, UK.
Olatunde AdesoroMalaria Consortium Nigeria, Abuja, Nigeria.
Rilwanu MohammedMalaria Consortium Nigeria, Abuja, Nigeria.
Jamilu NikauNational Malaria Elimination Programme, Abuja, Nigeria.
Chris Osa IsokpunwuNutrition Division, Federal Ministry of Health, Abuja, Nigeria.
Mohammad Ali InnameSokoto State Ministry of Health, Sokoto, Nigeria.
Helen CounihanMalaria Consortium United Kingdom, London, UK.
Kevin BakerMalaria Consortium United Kingdom, London, UK.
Kolawole MaxwellMalaria Consortium Nigeria, Abuja, Nigeria.
Helen SmithMalaria Consortium United Kingdom, London, UK.
Malaria Consortium · GBAIDS Prevention Initiative in Nigeria · NGFederal Ministry of Health · NGMalaria Consortium · USSokoto State University · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBi-annual high dose vitamin A supplements administered to children aged 6-59 months can significantly reduce child mortality, but vitamin A supplementation (VAS) coverage is low in Nigeria. The World Health Organization recommends that VAS be integrated into other public health programmes which are aimed at improving child survival. Seasonal malaria chemoprevention (SMC) provides a ready platform for VAS integration to improve health outcomes. This study explored the feasibility and acceptability of integrating VAS with SMC in one local government area in Sokoto State.

methodsA concurrent QUAN-QUAL mixed methods study was used to assess the feasibility and acceptability of co-implementing VAS with SMC in one LGA of Sokoto state. Existing SMC implementation tools and job aids were revised and SMC and VAS were delivered using a door-to-door approach. VAS and SMC coverage were subsequently assessed using questionnaires administered to 188 and 197 households at baseline and endline respectively. The qualitative component involved key informant interviews and focus group discussions with policymakers, programme officials and technical partners to explore feasibility and acceptability. Thematic analysis was carried out on the qualitative data.

resultsAt endline, the proportion of children who received at least one dose of VAS in the last six months increased significantly from 2 to 59% (p < 0.001). There were no adverse effects on the coverage of SMC delivery with 70% eligible children reached at baseline, increasing to 76% (p = 0.412) at endline. There was no significant change (p = 0.264) in the quality of SMC, measured by proportion of children receiving their first dose as directly observed treatment (DOT), at baseline (54%) compared to endline (68%). The qualitative findings are presented as two overarching themes relating to feasibility and acceptability of the integrated VAS-SMC strategy, and within each, a series of sub-themes describe study participants' views of important considerations in implementing the strategy.

conclusionThis study showed that it is feasible and acceptable to integrate VAS with SMC delivery in areas of high seasonal malaria transmission such as northern Nigeria, where SMC campaigns are implemented. SMC-VAS integrated campaigns can significantly increase vitamin A coverage but more research is required to demonstrate the feasibility of this integration in different settings and on a larger scale.

Indexed as

MalariaVitamin AChemopreventionChildDietary SupplementsFeasibility StudiesHumansLocal GovernmentNigeriaSeasonsVitamin AAcceptabilityFeasibilityHealth campaign effectivenessIntegrationIntervention coverageMicronutrient deficiencySeasonal malaria chemopreventionSMC plus vitamin A supplementationVitamin A supplementation

Identifiers

PMID35791014
PMCPMC9258179
OpenAlexW4284698665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.